How Seed Stage Biotech Navigate BD Engagement
- Discussing unique constraints of seed-stage companies when approaching BD engagement
- Maintaining relationships with big pharma and VCs when data is early and limited
- Outlining opportunities for creative deal structures, and when and where they would be appropriate